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Introduction
The importance of exercise for maintenance of a healthy life 
is well appreciated. Regular physical activity offers a variety of 
health benefits not only in the general, healthy population, 
but also in subjects with cardiac diseases. This idea is support-
ed by solid scientific evidence compiled over the past 50 years. 
The health benefits encompass all the aspects of life, from mere 
improvement in the physiologic functions, such as the cardio-
vascular/respiratory capacity and metabolic status, to achieve-
ment of hard end points, including reduction of the stroke and 
cancer risks, or even decrease in total mortality.
1) In spite of this 
general positive effect of exercise, exercise-related cardiac events 
are not infrequently reported during highly competitive sports 
activity or vigorous exercises.
2) In addition, certain groups of 
patients who have structural or genetic ion channel diseases are 
especially prone to develop life-threatening cardiac arrhythmias 
precipitated by vigorous physical exercise.
3)4) This review de-
scribes the general health benefit of regular physical exercise, 
as well as the potential adverse effects of vigorous exercise; it 
also identifies the subgroup of patients who are at higher risk 
of exercise-related sudden death, and finally screening meth-
ods to avoid the potential hazard of exercise. 
Benefits of Exercise 
Health benefits of physical exercise 
Prevention of coronary artery disease
Numerous epidemiologic studies have demonstrated a pro-
tective effect of exercise on coronary artery disease (CAD).
5) A 
recent meta-analysis showed that a moderate-to-high level of 
leisure time physical activity was associated with a reduced risk 
of CAD. Specifically, vigorous and moderate exercise decreased 
the risk of CAD by 27% and 12%, respectively, compared with 
individuals with low or nil exercise activity.
5) Possible contribu-
tion of exercise-induced blood pressure lowering, improved 
body composition, glucose tolerance, insulin sensitivity, and 
platelet function has been suggested.
6)
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Prevention of stroke
Studies on stroke prevention and meta-analysis of the stud-
ies
7-10) indicated that moderate- to high-intensity exercise was 
associated with a reduced stroke risk. This protective effect is 
not only confined to ischemic stroke, but also extends to re-
duction of hemorrhagic and, therefore, the total stroke risk.
7) 
Overall, moderately active individuals had a 20% lower risk 
and highly active individuals had a 27% lower risk of stroke in-
cidence or mortality than the low-active individuals.
8) Consid-
ering the pooled relative risk from studies on CAD and stroke 
prevention, the protective effect on stroke seemed comparable 
or even greater than the effect on CAD.
7) 
Hypertension is a risk factor for both ischemic and hemor-
rhagic strokes, and there is a direct dose-response relationship 
between blood pressure and stroke risk. Physical activity low-
ers blood pressure, improves lipid profiles, and also improves 
endothelial function, which enhances vasodilation and vaso-
motor function in the vessels. In addition, physical activity can 
play an antithrombotic role by reducing blood viscosity, fi-
brinogen levels, and platelet aggregability, all of which might 
reduce cardiac and cerebral events.
8)
Prevention of cancers
There have been numerous epidemiologic studies on physi-
cal activity and cancer prevention.
11) The available data indi-
cate that physical activity has a different association with dif-
ferent types of cancers.
11) Most studies focused on commonly 
occurring cancers (e.g., prostate, lung, colorectal for men, br-
east, lung, colorectal for women). The effect on the risk of co-
lon cancer varied from 80% reduction to 60% increase. Over-
all, exercise was associated with a lower risk of colon cancer 
among both men and women. In addition, a dose-response 
relationship in cancer prevention was observed across levels 
of physical activity.
11) In contrast, the available data show no 
clear association between physical activity and rectal cancer 
rates in men and women.
11) It also appears that physically ac-
tive women have a 20-30% reduced risk of breast cancer.
12) Al-
though exercise appears to be related with a lower risk of lung 
cancer, the confounding effect of smoking (passive smoking, 
depth of inhalation, use of filter tips etc) could not be complete-
ly controlled. There is no clear data supporting that physical 
activity decreases the risk of prostate cancer, with the median 
relative risk around 0.9. The data for other cancers, such as 
ovarian, testicular, pancreatic, kidney or bladder cancer, are 
limited. Although the beneficial effect of physical activity on 
the colon and breast cancers is obvious, the amount of exer-
cise, the duration or frequency of exercise, as well as the dose-
response relationship, is less clear. 
Reduction of mortality
A significant relationship between physical activity and re-
duction in mortality has been reported, with a mortality reduc-
tion reaching up to 20-40%.
13-16) A clear dose-response rela-
tionship was established and a larger volume of physical 
activity was related with a lower all-cause mortality.
14)15) This 
inverse dose-response relationship has been shown both in 
men and women, in younger and older subjects.
16) However, 
fewer data are available about the relationship between com-
ponents of exercise dose (duration, intensity, frequency) and 
the improvement in longevity.
15)
Other benefits
Other beneficial effects of exercise include modification of 
cardiovascular risk profiles, such as control of hypertension, 
improved lipid profile, prevention of type 2 diabetes, benefit on 
the bone-mineral metabolism and body composition.
17)
Dose-response relationship
Earlier studies evaluating the role of exercise focused primar-
ily on the beneficial effect of vigorous, sustained, aerobic exer-
cise. Later, it became clear from epidemiology and controlled 
experiments that moderate intensity physical activity can also 
show substantial health benefits.
17) Participation in physical ac-
tivities above minimum recommended amounts provides ad-
Table 1. Classification of physical activity according to the intensity of METs
Light (<3 METs) Moderate (3-6 METs) Vigorous (>6 METs)
Walking Walking slowly (2) Walking at brisk pace (3) Jogging, running (6)
Household or occupation Dish washing (2)
Ironing (2)
Making beds (2)
Work at desk (1-2)
Washing window (3)
Sweeping floor (3)
Vacuuming (3)
Mowing lawn (5)
Shoveling, digging dithes (7-8)
Leisure, sports Billiard (2-3)
Croquet (2-3)
Dart (2-3)
Fishing (2-3)
Musical instrument
Badminton (4)
Dancing (3-4)
Golf (4)
Bicycling (light) (6)
Swimming (light) (6)
Tennins (double) (5)
Basketball (8)
Soccer (7-10)
Skiing (7-9)
Bicycling (moderate/high) (8)
Swimming (moderate/high) (8-11)
Tennins (single) (8)
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ditional health benefits in a dose-dependent manner. Howev-
er, the point of maximum benefit for most health benefits has 
not been established, and may vary with many factors, such as 
age, sex, genetic or body composition.
18) Even more, recent re-
ports from the Women’s Health Initiative or Women’s Health 
Study confirmed that a physical activity of only one hour of 
walking per week may predict a significantly lower risk of 
CAD.
19-21) An important quotation regarding the amount of ex-
ercise beneficial for health is “Even a little is good, more is 
better.”, although this amount of activity might fall below the 
minimum requested in current guidelines.
22)23)
Exercise Recommendation
Exercise recommendations from the 1970s prescribed con-
tinuous, vigorous exercise for 20 minutes, 3 days per week.
24) 
Later consensus guideline recommended at least 30 minutes 
of accumulated, moderate-intensity activity per day, most 
days of the week.
18) The updated recommendation specified 
that “All healthy adults aged 18-65 need moderate-intensity 
aerobic physical activity for a minimum of 30 minutes on five 
days each week or vigorous-intensity aerobic activity for a 
minimum of 20 minutes on three days each week”.
25)
A convenient way to estimate the energy expenditure dur-
ing exercise is to calculate metabolic equivalents (METs) multi-
plied by exercise duration in minutes, where 1 MET corresponds 
to energy expenditure during sitted rest. The total, accumulat-
ed energy expenditure is the sum of the multiplication of 
METs of a specific physical activity and its duration. To meet the 
current recommendation, the minimum expenditure should 
be in the range of 450-750 MET×minutes per week.
25) One may 
calculate the approximate requirement of physical activity by 
this multiplication of intensity and duration, and thus be able 
to combine different levels of exercise to meet the recommend-
ed dose of exercise. For example, if one walked briskly for 30 
minutes three days a week (3 MET×30 minutes×3=270 
MET×minutes), and played soccer for 30 minutes twice a week (8 
MET×30 minutes×2=480 MET×minutes), the total energy 
expenditure would be 750 MET×minutes (Table 1).
25) 
Accumulation of shorter bouts of exercise (e.g., 10 minutes) 
towards the 30-minutes minimum can be as effective as sin-
gle, longer bouts.
25)26) Moreover, exercise may be compressed 
into fewer days of the week (e.g., exercise once or twice a week or 
on weekends only), with each activity session prolonged suf-
ficiently enough to fall within current guidelines.
21)25) The 2007 
physical activity recommendations for healthy adults devel-
oped by the American Heart Association and the American 
College of Sports Medicine is summarized in Table 2.
25)
Hazards of Exercise 
Exercise and sudden cardiac death 
(Cardiovascular risk of vigorous exercise)
Regular physical activity substantially reduces the incidence 
of CAD and may improve survival. However, it has also been 
known that vigorous physical activity can precipitate acute 
myocardial infarction (AMI) or sudden cardiac death.
2)27-29) 
A prospective study from the Veneto Region of Italy states that 
adolescents and young adults (<35 y.o.) engaged in competi-
tive sports have an increased risk of SCD, compared with their 
non-athletic counterparts (the annual incidence of SCD was 
2.3 in 100,000 in competitive athletes compared with 0.9 in non-
athletes, with an estimated relative risk of 2.5).
29) About 90% of 
all SCD were exercise-related in athletes, while only 9% of all 
SCD were related with exercise in the non-athletes group. It is 
generally accepted that sports, per se, is not a cause of increased 
mortality; rather, it acts as a trigger for cardiac arrest in the pres-
ence of underlying cardiovascular diseases predisposing to life-
threatening ventricular arrhythmias.
29)
For healthy adults, Thompson et al.
30) reported 1 death per 
year for every 7,620 joggers, and Siscovick et al.
2) estimated an 
annual rate of exercise-related cardiac arrest of 1 in 18,000 in 
previously healthy men.
The relative risk of SCD during vigorous exertion (mara-
thon running) was significantly elevated at 16.9, compared 
with other situations.
31) However, even with such intense 
Table 2. Physical activity recommendations for healthy adults aged 18-65 year
1..  To promote and maintain good health, adults aged 18-65 year should perform either moderate-intensity aerobic (endurance) 
  physical activity for a minimum of 30 minutes on five days each week or vigorous-intensity aerobic activity for a minimum of 20 minutes  
  on three days each week. 
2..  Combinations of moderate- and vigorous-intensity activity can be performed to meet this recommendation. For example, a person can
  meet the recommendation by walking briskly for 30 minutes twice during the week and then jogging for 20 minutes on two other days. 
3..  Moderate-intensity aerobic activity, which is generally equivalent to a brisk walk and noticeably accelerates the heart rate, 
  can be accumulated toward the 30-minutes minimum by performing several bouts, each lasting for 10 or more minutes. 
4..  In addition, at least twice each week adults will benefit by performing activities using the major muscles of the body that maintain 
  or increase muscular strength and endurance. 
5..  Because of the dose-response relation between physical activity and health, persons who wish to further improve their personal fitness, 
  reduce their risk for chronic diseases and disabilities, or prevent unhealthy weight gain will likely benefit by exceeding the minimum 
  recommended amount of physical activity. 
Modified from table 4, reference 25116   Exercise, Heart and Health
physical efforts, the absolute risk for SCD was exceedingly 
small (1 per 1.51 million episodes of exertion, or 1 in 215,000 
hours of running).
31)32) In fact, the U.S. Physicians’ Health 
Study, by comparing the relative risk of SCD according to the 
frequency of habitual vigorous exercise, demonstrated that 
habitual vigorous exercise diminishes the risk of sudden death 
during vigorous exertion.
31) Precipitation of AMI follows a sim-
ilar pattern. Although there is an increased risk of develop-
ment of AMI with vigorous exercise, the risk is highest in in-
dividuals with low levels of habitual activity.
27)33) Overall, the 
relative risk is lowest in the most physically active, while the 
relative risk is highest in sedentary individuals.
Cardiac pathology of exercise-related 
sudden cardiac death
It has been shown that acute cardiac events during exercise 
occur predominantly in individuals with structural heart dis-
eases, and the distribution of cardiac diseases is dependent on 
ages. In individuals aged <35 years, cardiomyopathies or con-
genital heart diseases were responsible for the majority of the 
SCD victims, whereas CAD was the most frequent cause of 
death among older individuals (≥35 years).
27)28)34-37) The differ-
ent distribution of cardiovascular diseases between the two 
countries may be attributable to systematic pre-participation 
screening, leading to identification of athletes with hypertro-
phic cardiomyopathy (HCM) in Italian athletes (Table 3). 
Mechanism of sudden cardiac death or ventricular 
fibrillation during sympathetic stimulation
Acute ischemia and sympathetic activation
CAD is the most common cause of SCD in older subjects. 
Even in previously asymptomatic adults, coronary artery pla-
que disruption (rupture or erosion) with acute thrombotic oc-
clusion can be found. However, the mechanism by which vig-
orous exercise precipitates cardiac events is not clearly defined. 
Exercise-related physiologic changes, such as elevated blood 
pressure, increased heart rate, coronary artery spasm in the af-
fected artery segment, may contribute to the plaque disrup-
tion. Other contributing factors include deepening of the coro-
nary fissures, as well as catecholamine-induced platelet acti-
vation and aggregation. Once myocardial blood flow is severe-
ly impaired in acute ischemia, ATP-sensitive potassium channels 
open and, together with hyperkalemia or cellular acidosis, lead 
to a markedly increased dispersion of repolarization and cell-
to-cell conduction, which ultimately leads to ventricular fibril-
lation (VF).
38)
Congestive heart failure
The most prominent cellular electrophysiological alteration 
seen in failing heart is prolongation of the action potential du-
ration. This is caused by down-regulation of the K
+ currents 
and alteration in the inward Na
+ and Ca
++ currents. This action 
potential prolongation occurs inhomogeneously throughout 
the transmural myocardium, and serves as a substrate for re-
entrant ventricular tachyarrhythmias.
39)40) In addition, altered 
channel gating property of the RyR receptor, reduced sarco-
plasmic reticulum (SR) Ca
++ ATPase function and increased 
Na-Ca exchange contribute to spontaneous Ca
++ leak, decreas-
ed SR Ca
++ contents, and reduced Ca
++ transient. These chang-
es, in association with up-regulated Na-Ca exchange and re-
duced inward rectifier K
+ current, lead to contractile dysfunc-
tion and development of delayed afterdepolarization.
41)42) 
Upon sympathetic stimulation, spontaneous Ca
++ release and 
enhanced Na-Ca exchange, together with IK1 reduction, re-
sults in greater propensity for developing delayed after-depo-
larization.
43)
Hypertrophic cardiomyopathy 
In a large multicenter ICD registry, ventricular tachyar-
rhythmias appeared to play a major role in the pathogenesis 
of SCD in HCM, while bradyarrhythmia-mediated events 
could not be excluded as a cause of SCD.
44) As sinus tachycar-
dia was often the initiating rhythm before development of ven-
tricular tachyarrhythmias, high sympathetic drive seemed to 
be proarrhythmic in patients with HCM.
45)
It has been shown that the histological features of HCM are 
a markedly disorganized myocardial architecture, medial 
Table 3. Causes of sudden death in young adults
U.S. athletes (%)
Italy, athletes & 
non-athletes (%)
HCM 215 (36.2) 17 (6.3)
CA anomaly 119 (17.2) 07 (2.6)
Possible HCM 57 (8.2)
Myocarditis 41 (5.9) 22 (8.2)
ARVC 30 (4.3) 029 (10.8)
Ion channel disease 25 (3.6)
MVP 24 (3.4) 26 (9.7)
LAD bridge 23 (3.3) 07 (2.6)
CAD 23 (3.3) 045 (16.7)
Aortic rupture 19 (2.8) 12 (4.5)
AS 17 (2.5)
Dilated CM 14 (2.0) 10 (3.7)
WPW 11 (1.6)
Conduction system disease 24 (8.9)
Other 36 (5.2) 070 (29.0)
Total 690 (100). 269 (100).
Modified from references 28, 35. ARVC: arrhythmogenic right ven-
tricular cardiomyopathy, AS: aortic stenosis, CA: coronary artery, 
CAD: coronary artery disease, CM: cardiomyopathy, CV: cardio-
vascular, HCM: hypertrophic cardiomyopathy, LAD: left anterior 
descending coronary artery, MVP: mitral valve prolapse, WPW: 
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hypertrophy with luminal narrowing of the intramural coro-
nary arteries, and replacement fibrosis after bursts of myocar-
dial ischemia or myocyte necrosis.
46) This highly heteroge-
neous substrate may be prone to develop ventricular tachyar-
rhythmias during exercise, due to outflow tract obstruction, 
myocardial ischemia or sympathetic surge, as previously de-
monstrated.
47-49)
Arrhythmogenic right ventricular dysplasia
Arrhythmogenic right ventricular dysplasia (ARVD) is an 
inherited cardiomyopathy in which the right ventricular myo-
cardium is progressively replaced by fat and fibrosis. SCD is fre-
quently the first manifestation of the disease, and it occurs rel-
atively frequently during exercise or stress. RV dilation, precordial 
repolarization abnormalities, and LV involvement have been 
associated with higher risk of sudden death.
50)
Coronary artery anomaly
Congenital coronary artery anomaly indicates either the 
left main coronary artery arising from the right aortic sinus/
pulmonary artery, or the right coronary artery arising from 
the left aortic sinus. Overall, it is an important cause of sud-
den death in young athletes. Cardiac events occur mainly dur-
ing intense exertion probably provoked by myocardial isch-
emia from angulation of the coronary ostium or compression 
of the coronary artery. Premonitory symptoms (syncope, chest 
pain) may occur shortly before the onset of sudden death. 
Echocardiography or stress electrocardiogram (ECG) with ma-
ximal exercise may not disclose this anomaly, and a careful 
history taking revealing the presence of syncope or chest pain 
during exercise is crucial in the pre-participation screening of 
competitive athletes.
51) 
Myocardial bridge
Myocardial bridging is defined as a segment of a major epi-
cardial coronary artery running intramurally through the myo-
cardium, and is a common angiographic or autopsy finding. It 
is generally a benign congenital coronary artery anomaly, but 
it has been associated with angina, arrhythmia, depressed left 
ventricular (LV) function, myocardial stunning, and sudden 
death.
52) Medical treatment with beta-blockers seems to be the 
first choice. However, intracoronary stents and surgery have 
been attempted in selected patients with refractory symptoms. 
Additional study is necessary to define the role of the myocar-
dial bridge in the occurrence of sudden death, and to select the 
patients requiring invasive or surgical management.
52)53)
Myocarditis
Myocarditis accounts for about 10% of the SCD in the young 
population. Infection or exposure to toxic chemicals/radiation 
can cause myocardial inflammation, and SCD results from 
conduction abnormalities or malignant ventricular tachyar-
rhythmias.
50)
Mitral valve prolapse
The mitral valve prolapase (MVP) is a common echocardio-
graphic abnormality, observed in about 3-4% of the general 
population. It is not a single disease entity, but a spectrum of 
different conditions, ranging from simple bowing of the mi-
tral valve leaflet to redundant myxomatous leaflet and flail 
MV. 
54)55) 
Although SCD frequently occurs during exercise, the MVP 
per se. may not be related with an increased risk of SCD. In-
stead, the risk of SCD is strongly associated with accompany-
ing mitral regurgitation.
54)55) The mechanism of SCD in pa-
tients with MVP is not clear. Ventricular tachyarrhythmias 
have been reported to occur more frequently in patients with 
MVP than in control subjects. However, this may be due to the 
presence of mitral regurgitation, not due to MVP itself. There-
fore, the cause of SCD seems multifactorial, including ven-
tricular tachyarrhythmias or atrioventricular block, hemody-
namic dysfunction with severe hypotension, coronary artery 
spasm, hidden myocarditis or myocardial dysplasia.
56)
The Wolff-Parkinson-White syndrome
The risk of SCD associated with ventricular preexcitation is 
less than 0.15% per year.
57) The main mechanism of SCD seems 
to be atrial fibrillation conducting rapidly over an accessory 
pathway and degenerating into VF.
58) Exercise is associated with 
an increased risk of VF. The approach to asymptomatic patients 
with ventricular preexcitation varies from simple observation 
to routine electrophysiological study and catheter ablation of 
the accessory pathway in patients with inducible atrial tachyar-
rhythmia.
58) Considering the low risk of SCD in this aymptom-
atic population, the clinical decision should be individualized. 
Athletes with ventricular preexcitation should be evaluated for 
inducibility of supraventricular tachycardia and refractori-
ness of the accessory pathway before participation in compet-
itive sports.
69)
Long QT syndrome
It has been well demonstrated that subgroups of patients 
with long QT syndrome (LQTS) are sensitive to sympathetic 
stimulation. Arrhythmic events are often associated with physi-
cal exercise, emotional stress or auditory stimulation in long 
QT type 1 or 2.
59) Swimming is a relatively genotype-specific ar-
rhythmogenic trigger for both type 1 of the long QT syndrome 
and catecholaminergic polymorphic ventricular tachycardia 
(CPVT). In contrast, type 2 LQTS patients are susceptible to 
auditory stimulation or alarm.
59)60)
Catecholaminergic polymorphic ventricular tachycardia
CPVT is an inherited disease characterized by a normal rest-
ing ECG, adrenergically-mediated bigemini premature ven-118   Exercise, Heart and Health
tricular contraction (PVC) and ventricular tachyarrhythmias. 
Mutation of the cardiac Ryanodine receptor 2 with impaired 
calcium-handling and delayed afterdepolarization was demon-
strated to be the electrophysiological mechanism of fatal ven-
tricular tachyarrhythmias.
61)62)
Other genetic arrhythmia syndromes
Cardiac events in patients with short QT syndrome may oc-
cur during effort or loud noise, but this association appears to 
be weaker than in both LQTS and CPVT.
63-65) The arrhythmo-
genic mechanism in patients with Brugada syndrome or early 
repolarization syndrome is strongly dependent on the vagal 
nerve activity, and exercise is less strictly prohibited compared 
with patients with LQTS, CPVT or HCM.
66) 
Exercise recommendations in patients 
with genetic cardiovascular diseases
Patients with Exercise recommendations in patients with ge-
netic cardiovascular diseases (GCVDs) are at higher risk for 
SCD during exercise compared with normal subjects. The con-
flict between the known benefits and potential adverse out-
comes of exercise requires careful weighing of the perceived 
risk to benefit ratio for each patient. It is generally recommend-
ed that patients with GCVDs can safely participate in most 
forms of recreational exercise of moderate or low intensity 
(i.e., equivalent to or lower than 6 METs). Activities requiring 
sudden acceleration or deceleration (burst exertion), exercise 
under extreme adverse environmental conditions, intense static 
exertion (weight lifting), exercises with potential risk of trau-
matic injury associated with loss of consciousness (free-weight 
lifting, rock climbing or ice hockey) or with possibilities of im-
paired consciousness during water-related activities are gen-
erally either not advised or strongly discouraged in all forms of 
genetic cardiovascular diseases.
34)66) In addition, individual 
clinical judgment is required for patients with high risk clini-
cal features, such as history of important cardiac symptoms, 
including syncope, prior cardiac operation, heart transplanta-
tion, presence of an implanted cardioverter-defibrillator or pace-
maker, potentially life-threatening arrhythmias or other evi-
dence of high-risk status. 
Preparticipation screening
Due to the risk of exercise-related sudden death or other car-
diac events, pre-participation screening for the susceptible sub-
jects has emerged as an important issue in exercise recommen-
dation. Brief guidelines for preparticipation are as follows.
Athletes
In Italy, a national pre-participation screening mandates 
annual evaluations that routinely include 12-lead ECG, in ad-
dition to medical history and physical examination. Wide im-
plementation of the Italian screening model has been promot-
ed by the endorsement of the European Society of Cardiology 
in 2005. Recent scientific evidence demonstrated this screen-
ing strategy to be useful for identification of HCM and other 
cardiomyopathies in asymptomatic athletes,
67) and implemen-
tation of this program in Italy has been associated with sub-
stantial reduction in mortality due to cardiomyopathies.
68) On 
the other hand, customary screening strategies for U.S. high 
school and college athletes is confined to medical history and 
physical examination at 2- to 4-year intervals.
34) This is due to 
current lack of medical and financial resources, and more im-
portantly, due to potentially deleterious effects to many ath-
letes by virtue of false-positive test results that would lead to 
unnecessary further evaluation or disqualification.
To overcome this controversy, a new classification of the ath-
lete ECG was proposed. ECG may be abnormal in up to 50% of 
athletes, which hinders the widespread use of ECG as part of 
the pre-participation screening. This new guideline classifies 
the changes seen on the athlete ECG into physiological (com-
mon and training-related) and pathological (uncommon and 
training-unrelated), to lower the traditionally high number 
of false-positive results and thus reducing unnecessary inves-
tigations
69) (Table 4).
Table 4. Classification of abnormalities seen on the electrocardiogram recorded in subjects with athlete’s heart 
Group 1: common and training-related ECG changes Group 2: uncommon and training-unrelated ECG changes
Sinus bradycardia 
First-degree AV block 
Incomplete RBBB 
Early repolarization 
Isolated QRS voltage criteria for left ventricular hypertrophy
T-wave inversion
ST-segment depression
Pathological Q-waves
Left atrial enlargement
Left-axis deviation/Left anterior hemiblock
Right-axis deviation/Left posterior hemiblock
Right ventricular hypertrophy
Ventricular pre-excitation
Complete LBBB or RBBB
Long- or short-QT interval
Brugada-like early repolarization
Adapted from references 69. ECG: electrocardiogram, RBBB: right bundle branch block, LBBB: left bundle branch blockGi-Byoung Nam   119
Non-athletes
Guidelines from the AHA indicated that exercise testing is 
not necessary for all people beginning a moderate intensity 
physical activity program. The rationale is based on the ex-
tremely low rate of cardiovascular complications in asymp-
tomatic persons while performing moderate-intensity physi-
cal activity, on the poor predictive value of exercise testing for 
acute cardiac events and on the high costs of mass exercise test-
ing. Symptomatic subjects or those suffering from any cardio-
vascular disease, diabetes, other active chronic disease, or with 
any medical concern in general, should consult a physician 
prior to any substantive increase in physical activity, particu-
larly vigorous-intensity activity.
25)
Other issues or adverse effects of exercise; 
the athletes’ heart and commotio cordis 
The athlete’s heart
Exercise-related cardiac events occur predominantly in sub-
jects with underlying structural abnormalities. However, exer-
cise may cause a deleterious effect in individuals without un-
derlying cardiac diseases. Athlete’s heart denotes exercise-
related electrical and structural remodeling. Intense resistance 
training increases LV wall thickness and mass with little or no 
change in the LV diameter, while aerobic exercise is associated 
with asymmetric LV hypertrophy.
70)71)
Clinical implications of the athlete’s heart include differen-
tial diagnosis from hypertrophic/dilated/RV cardiomyopathy, 
or possible long-term consequences of the extreme LV remod-
eling. As exercise itself causes alteration in the cardiac chamber 
size and morphology resembling those of cardiomyopa-
thies, differential diagnosis of the athlete’s heart (i.e., a physio-
logical adaptation) from cardiomyopathies has long been a di-
agnostic dilemma. Athletes with benign right ventricular out-
flow tract VT may show wall motion abnormalities mimicking 
ARVD. In addition, concern has been raised that uninterrupt-
ed training per se, might ultimately cause irreversible cardiac 
dilatation,
71) systolic dysfunction,
72) or even ventricular tachyar-
rhythmias.
73) A recent report, however, demonstrated that even 
young Olympic athletes exposed to extreme endurance train-
ing over long periods of time (up to 17 years) did not show de-
terioration in LV function and morphology or any occurrence 
of cardiovascular events. These findings confirmed the concept 
that the athlete’s heart is a physiological adaptation to exercise, 
not causing irreversible cardiac remodeling.
74)
Commotio cordis
Commotio cordis refers to VF and SCD triggered by a blunt, 
non-penetrating, and often innocent-appearing blow to the 
chest wall, without visible damage to the ribs, sternum, or heart, 
in individuals without previous structural heart diseases. It is 
an important cause of exercise-related SCD in young athletes, 
accounting for 3% of all sudden deaths in young, competitive 
athletes.
75) A direct blow to the chest walls falling on a critical 
time of the cardiac cycle (i.e., 10-20 msec on the upstroke of the 
T wave) can precipitate VF. The cellular mechanism of VF ini-
tiation appears to be multifactorial. Instantaneous increase in 
the left ventricular intra-cavitary pressure and opening of st-
retch-activated ion channels, including ATP-sensitive potassi-
um channels, may result in inhomogeneous repolarization of 
the myocardium, thus creating the vulnerable substrate for 
VF.
76)
Conclusion
Regular physical activity provides a variety of health bene-
fits, including improvement in the cardiopulmonary or meta-
bolic status, reduction of the risk of CAD or stroke, prevention 
of cancer, and decrease in total mortality. These benefits offset 
the small but significant increase in the risk of SCD during vig-
orous exercise. There is a subgroup of patients, however, par-
ticularly at higher risk of sudden death during exercise. Proper 
identification of patients with hidden CADs, as well as screen-
ing of young subjects with structural or genetic ion channel 
diseases, may prove important for the prevention of exercise-
related sudden death. 
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